NAPRIX A 5 MG + 5 MG CAP GEL DURA CT FR PLAS X 10
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1003300960281 -
GGREM
523724060052903 -
Código de barras
7896094212565
O que a fonte publica
- Detentor do registro
- LIBBS FARMACÊUTICA LTDA
- Princípios ativos
- BESILATO DE ANLODIPINO;RAMIPRIL
- Embalagem
- 5 MG + 5 MG CAP GEL DURA CT FR PLAS X 10
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- C9B3 - INIBIDORES DA ECA ASSOCIADOS A ANTAGONISTAS DO CÁLCIO (C8)
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "NAPRIX A 5 MG + 5 MG CAP GEL DURA CT FR PLAS X 10",
"holder": "LIBBS FARMACÊUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896094212565"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "523724060052903",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.230.314/0001-75",
"priceRegime": "Regulado",
"productName": "NAPRIX A",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "5 MG + 5 MG CAP GEL DURA CT FR PLAS X 10",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "16.05",
"icms-12": "18.24",
"icms-17": "19.34",
"icms-18": "19.57",
"icms-19": "19.81",
"icms-20": "20.06",
"icms-21": "20.32",
"icms-22": "20.58",
"icms-23": "20.84",
"icms-17.5": "19.45",
"icms-19.5": "19.94",
"icms-20.5": "20.19",
"icms-22.5": "20.71",
"icms-12-alc": "18.02",
"icms-17-alc": "19.11",
"icms-18-alc": "19.34",
"icms-19-alc": "19.58",
"icms-20-alc": "19.82",
"icms-21-alc": "20.07",
"icms-22-alc": "20.33",
"icms-23-alc": "20.59",
"withoutTaxes": "15.86",
"icms-17.5-alc": "19.22",
"icms-19.5-alc": "19.70",
"icms-20.5-alc": "19.95",
"icms-22.5-alc": "20.46"
},
"pisCofinsList": "Positiva",
"substanceText": "BESILATO DE ANLODIPINO;RAMIPRIL",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "22.12",
"icms-12": "25.14",
"icms-17": "26.66",
"icms-18": "26.98",
"icms-19": "27.31",
"icms-20": "27.65",
"icms-21": "28.01",
"icms-22": "28.37",
"icms-23": "28.73",
"icms-17.5": "26.81",
"icms-19.5": "27.49",
"icms-20.5": "27.83",
"icms-22.5": "28.55",
"icms-12-alc": "24.91",
"icms-17-alc": "26.42",
"icms-18-alc": "26.74",
"icms-19-alc": "27.07",
"icms-20-alc": "27.40",
"icms-21-alc": "27.75",
"icms-22-alc": "28.11",
"icms-23-alc": "28.46",
"withoutTaxes": "21.92",
"icms-17.5-alc": "26.57",
"icms-19.5-alc": "27.23",
"icms-20.5-alc": "27.58",
"icms-22.5-alc": "28.28"
},
"invalidBarcodes": [],
"activeSubstances": [
"BESILATO DE ANLODIPINO",
"RAMIPRIL"
],
"therapeuticClass": "C9B3 - INIBIDORES DA ECA ASSOCIADOS A ANTAGONISTAS DO CÁLCIO (C8)",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1003300960281",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "C9B3",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:523724060052903"